Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
The MeCo Score is a prognostic and predictive biomarker that stratifies early-stage breast cancer patients for risk of metastasis caused by mechanical conditioning, and it provides the rationale for targeted prevention in high-risk patients using low-toxicity antifibrotic drugs as "mechanical deconditioning therapy."
The MeCo Score (TM) is an investigational assay that is not approved or demonstrated to be safe or effective for any use.
Copyright © 2022 MeCo Diagnostics HOLDINGS, INC. - All Rights Reserved.